Anika Therapeutics Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Gain 2.67%

The Anika Therapeutics Inc. stock price gained 1.09% on the last trading day (Monday, 13th Jul 2026), rising from $15.60 to $15.77. During the last trading day the stock fluctuated 3.74% from a day low at $15.51 to a day high of $16.09. The price has been going up and down for this period, and there has been a 4.44% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 27 thousand more shares were traded than the day before. In total, 74 thousand shares were bought and sold for approximately $1.16 million.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $16.35 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Anika Therapeutics Inc. stock with a 90% probability to be traded between $12.67 and $16.53 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ANIK Signals & Forecast

The Anika Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.87. On a fall, the stock will find some support from the long-term average at approximately $14.91. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Anika Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -3.49%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Anika Therapeutics Inc. stock

Anika Therapeutics Inc. finds support from accumulated volume at $15.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.580 between high and low, or 3.74%. For the last week, the stock has had daily average volatility of 4.15%.

Our recommended stop-loss: $15.01 (-4.85%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (ANIK) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Anika Therapeutics Inc. to open at $15.79, and during the day (based on 14 day Average True Range), to move between $15.48 and $16.06, which gives a possible trading interval of +/-$0.589 (+/-3.81%) up or down from last closing price. If Anika Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 3.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.82 (0.32%) than the support at $15.30 (2.98%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anika Therapeutics Inc. stock A Buy?

Anika Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.148 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $15.79 ( 0.127%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk